Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Joby Aviation Q1 2026 Earnings Call - EIPP Selection and Manufacturing Ramp Accelerate
Joby Aviation's Q1 2026 results underscore a critical inflection point in the eVTOL commercialization timeline. The company secured its spot in the White House-backed EIPP program across 11 states, en...
- Joby selected for the White House-backed EIPP program across 11 states, including Texas, New York, and Florida, enabling pre-certification passenger operations this year.
- Successful demonstration flights connected JFK to Manhattan heliports and operated within Class B airspace, proving operational maturity in dense urban environments.
- Manufacturing is accelerating with parts being produced for the ninth conforming aircraft and a third shift added to composites and automated fiber placement teams.
- +7 more takeaways
SuRo Capital Q1 2026 Earnings Call - NAV Surges 76% Amid Strategic Magnetar Partnership
SuRo Capital delivered its largest quarterly NAV increase in history, jumping 76% to $14.24 per share, driven by massive unrealized gains across a concentrated portfolio of high-growth private compani...
- SuRo Capital’s NAV surged 76% quarter-over-quarter from $8.09 to $14.24 per share, marking the largest quarterly increase in company history.
- The valuation jump was primarily driven by a $6.25 per share increase in unrealized appreciation across the portfolio, partially offset by a $0.16 per share net investment loss.
- Top five holdings, including Whoop, OpenAI, and Vast Data, now represent approximately 72% of the investment portfolio, highlighting a highly concentrated strategy.
- +7 more takeaways
Live Nation Q1 2026 Earnings Call - Global Supply Surge and Venue Nation Expansion Offset Ticketing Headwinds
Live Nation reported a strong start to 2026, driven by a global expansion in concert supply and robust demand across all venue types. CEO Michael Rapino highlighted that the "pie" of touring activity ...
- Global supply of touring artists is expanding rapidly, with strong growth across all venue types from clubs to stadiums, driven by international markets including Latin America, Asia, and K-pop acts.
- Amphitheaters are rebounding strongly in 2026, with double-digit growth in show counts and ticket sales, offsetting last year’s supply-side stumbles and demonstrating resilient demand.
- Venue Nation strategy is accelerating, with a focus on both building new venues and partnering with existing sports stadiums in Latin America to lock in revenue streams with lower capital intensity.
- +7 more takeaways
Klaviyo Q1 2026 Earnings Call - AI Agents Drive Record Margins and Enterprise Consolidation
Klaviyo delivered a quarter that underscored the shift from basic marketing automation to autonomous consumer relationship management. Revenue grew 28% year-over-year to $358 million, while non-GAAP o...
- Revenue grew 28% year-over-year to $358 million, beating expectations and driving a raise in full-year guidance.
- Non-GAAP operating margin expanded to a record 16%, marking the highest level since the company went public.
- Klaviyo achieved its first quarter of positive GAAP operating margin since its IPO, driven by margin expansion and reduced stock-based compensation.
- +7 more takeaways
Jazz Pharmaceuticals Q1 2026 Earnings Call - Record Revenue Driven by Zepzelca and XYWAV Momentum
Jazz Pharmaceuticals delivered a record first quarter of 2026, with total revenues surging 19% year-over-year to $1.1 billion. The growth was broad-based, fueled by double-digit expansions across all ...
- Total first-quarter 2026 revenue hit a record $1.1 billion, reflecting 19% year-over-year growth.
- Zepzelca sales surged 60% to $101 million, driven by rapid uptake in the first-line maintenance setting for extensive stage small cell lung cancer.
- XYWAV net product sales increased 18% to $408 million, with 425 net patient adds and 16,600 active patients.
- +7 more takeaways
Neurocrine Biosciences Q1 2026 Earnings Call - Commercial Momentum Accelerates as Pipeline Catalysts Loom in 2027
Neurocrine Biosciences delivered a quarter of undeniable momentum, with total revenue surpassing $800 million for the first time in company history. INGREZZA continues to defy gravity nine years post-...
- Total revenue exceeded $800 million for the first time in company history, representing a 44% year-over-year increase.
- INGREZZA sales reached $657 million, up 20% year-over-year, with management reaffirming 2026 guidance of $2.7 to $2.8 billion.
- CRENESSITY sales annualized past $600 million, driven by steady new patient starts, high persistence, and favorable reimbursement dynamics.
- +7 more takeaways
Versigent Q1 2026 Earnings Call - Strong Start as Standalone with Copper Headwinds and Dividend Launch
Versigent delivered a robust first quarter as an independent company, with revenue rising 9% year-over-year to $2.2 billion and adjusted EBITDA margin holding at 9.2%. The results reflect strong under...
- Revenue grew 9% year-over-year to $2.2 billion, with 3% adjusted growth after excluding FX and commodity pass-throughs.
- Adjusted EBITDA reached $203 million, maintaining a 9.2% margin, though diluted by copper and currency impacts.
- New bookings totaled $2.6 billion, marking the start of 24 new programs and the most major launches in company history.
- +7 more takeaways
Arista Networks Q1 2026 Earnings Call - AI Demand Outpaces Supply, Guiding 27.7% Growth
Arista Networks delivered a robust Q1 2026, with revenue of $2.71 billion (+35% YoY) and raised its full-year growth forecast to 27.7%, targeting $11.5 billion. The company is commanding #1 market sha...
- Revenue of $2.71 billion grew 35.1% year-over-year, beating guidance of $2.6 billion.
- Full-year 2026 revenue growth forecast raised to 27.7%, targeting approximately $11.5 billion.
- AI fabric revenue target increased to $3.5 billion, more than doubling from prior year.
- +7 more takeaways
Lumen Technologies Q1 2026 Earnings Call - Alkira Acquisition Completes Digital Architecture, FCF Guidance Raised
Lumen Technologies reported a solid Q1 2026, with revenue and EBITDA in line with expectations and above consensus. The company’s strategic pivot toward programmable networking and AI-driven infrastru...
- Lumen announced its intent to acquire Alkira for $475 million in cash, targeting a Q3 2026 close to complete its digital architecture.
- The Alkira acquisition extends Lumen’s programmable network into east-west cloud connectivity, complementing existing north-south capabilities.
- Management expects Alkira to accelerate roadmap execution from years to months, inject talent, and provide a marketplace-ready platform.
- +11 more takeaways
Marqeta Inc. Q1 2026 Earnings Call - Marqeta Hits GAAP Profitability as Non-Block Growth Surges 33%
Marqeta delivered a strong first quarter 2026, posting $166 million in net revenue, up 19% year-over-year, driven by a 33% surge in transaction volume. The company achieved its first GAAP net income o...
- Marqeta reported Q1 2026 net revenue of $166 million, up 19% year-over-year, with gross profit reaching $118 million, also up 19%. Transaction volume grew 33% to $112 billion, marking the second consecutive quarter with TPV exceeding $100 billion. The company achieved its first GAAP net income of $8 million, with adjusted EBITDA surging 66% to $33 million and a 20% margin. Block's revenue concentration fell to 42%, as non-Block business grew at twice the pace, indicating successful customer diversification. Twelve of Marqeta's top 15 customers now operate in multiple countries, highlighting strong demand for multinational card issuing capabilities. BNPL growth remained robust at nearly 60% year-over-year, while expense management grew over 40%, driven by existing customer expansion. Management reiterated full-year net revenue guidance of 12-14% growth but lifted full-year adjusted EBITDA growth to the mid-to-high twenties%. Marqeta expects to be at GAAP breakeven in Q2 2026, with full-year net income guidance increased by $5 million to approximately $15 million. Block's new issuance decline is being pushed into the second half of the year, reducing the full-year gross profit headwind to 1.5 percentage points. The company is exploring stablecoin-backed card programs and agentic payment use cases, positioning its flexible credential technology for emerging fintech trends.
- company_name
- quarter
- +7 more takeaways